Legal & General Group Plc Has $234.29 Million Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• Legal & General Group Plc trimmed its stake in GE HealthCare Technologies by 1.5% in the fourth quarter, but still held 2.86 million shares worth about $234.29 million. Institutional investors overall remain heavily involved, owning about 82.06% of the stock.
• GE HealthCare reported Q1 earnings of $0.99 per share, missing estimates, while revenue came in at $5.13 billion, above expectations and up 7.4% from a year ago. The company also reaffirmed guidance, setting FY 2026 EPS guidance at 4.800-5.000.
• Insider buying has been notable, with CFO James Saccaro and Director Kevin Lobo both purchasing shares recently. Analysts remain mixed but constructive overall, with a consensus rating of Moderate Buy and an average price target of $80.21.

Legal & General Group Plc lowered its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 1.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,856,521 shares of the company's stock after selling 44,414 shares during the quarter. Legal & General Group Plc owned approximately 0.63% of GE HealthCare Technologies worth $234,292,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $26,000. Optima Capital LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $27,000. Montag A & Associates Inc. lifted its stake in shares of GE HealthCare Technologies by 105.4% during the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company's stock worth $28,000 after buying an additional 175 shares during the last quarter. Maseco LLP acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $29,000. Finally, Eagle Bay Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth about $33,000. Institutional investors and hedge funds own 82.06% of the company's stock.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $63.88 on Thursday. GE HealthCare Technologies Inc. has a twelve month low of $58.75 and a twelve month high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a 50-day simple moving average of $68.03 and a two-hundred day simple moving average of $76.03. The stock has a market capitalization of $29.06 billion, a price-to-earnings ratio of 15.28, a price-to-earnings-growth ratio of 1.45 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the firm earned $1.01 EPS. GE HealthCare Technologies's revenue for the quarter was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CFO James Saccaro acquired 3,310 shares of the company's stock in a transaction on Friday, May 1st. The stock was acquired at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares of the company's stock, valued at $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Kevin Lobo bought 10,000 shares of the firm's stock in a transaction on Friday, May 22nd. The stock was purchased at an average cost of $64.18 per share, for a total transaction of $641,800.00. Following the completion of the acquisition, the director owned 14,363 shares in the company, valued at approximately $921,817.34. This trade represents a 229.20% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have acquired 21,847 shares of company stock worth $1,361,355. 0.36% of the stock is currently owned by insiders.

Analysts Set New Price Targets

GEHC has been the subject of a number of research reports. Citigroup cut their target price on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a "neutral" rating for the company in a research note on Thursday, April 30th. Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research note on Wednesday, February 4th. Oppenheimer restated an "outperform" rating and set a $85.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Argus cut their target price on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a "buy" rating for the company in a research note on Tuesday, May 19th. Finally, UBS Group upgraded shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and cut their target price for the stock from $75.00 to $69.00 in a research note on Thursday, May 21st. Nine analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $80.21.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.